NCT06070597View on ClinicalTrials.gov

A Study in Healthy People to Test Whether Iclepertin Has an Effect on Cardiac Safety

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

January 25, 2024

Primary Completion Date

June 5, 2024

Study Completion Date

June 5, 2024

Conditions
Healthy
Interventions
DRUG

Iclepertin

Iclepertin

DRUG

Iclepertin Placebo

Placebo to Iclepertin

DRUG

Moxifloxacin

Moxifloxacin

DRUG

Moxifloxacin Placebo

Placebo Moxifloxacin

Trial Locations (1)

68167

CRS Clinical Research Services Mannheim GmbH, Mannheim

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY